Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

703 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Phase I study of phenylacetate administered twice daily to patients with cancer.
Thibault A, Samid D, Cooper MR, Figg WD, Tompkins AC, Patronas N, Headlee DJ, Kohler DR, Venzon DJ, Myers CE. Thibault A, et al. Among authors: figg wd. Cancer. 1995 Jun 15;75(12):2932-8. doi: 10.1002/1097-0142(19950615)75:12<2932::aid-cncr2820751221>;2-p. Cancer. 1995. PMID: 7773944 Clinical Trial.
Antitumor activity of suramin in hormone-refractory prostate cancer controlling for hydrocortisone treatment and flutamide withdrawal as potentially confounding variables.
Dawson NA, Cooper MR, Figg WD, Headlee DJ, Thibault A, Bergan RC, Steinberg SM, Sausville EA, Myers CE, Sartor O. Dawson NA, et al. Among authors: figg wd. Cancer. 1995 Aug 1;76(3):453-62. doi: 10.1002/1097-0142(19950801)76:3<453::aid-cncr2820760316>;2-e. Cancer. 1995. PMID: 8625127 Clinical Trial.
Suramin-induced neutropenia.
Dawson NA, Lush RM, Steinberg SM, Tompkins AC, Headlee DJ, Figg WD. Dawson NA, et al. Among authors: figg wd. Eur J Cancer. 1996 Aug;32A(9):1534-9. doi: 10.1016/0959-8049(96)00139-6. Eur J Cancer. 1996. PMID: 8911114
703 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page